Seer is a proteomics technology company dedicated to pioneering efficient nanoparticle-based workflows for large-scale plasma and serum analysis. Their core mission is to decode the secrets of the proteome to improve human health by empowering the scientific community with advanced tools. Seer's flagship product, the Proteograph™ Suite, offers robust and unbiased proteomics services, targeting researchers and institutions focused on deep proteomic analysis.
Seer has made significant strides in the field of proteomics, enabling large-scale plasma and serum analysis for the first time. Their innovative approach has eliminated many technological barriers, allowing proteomics to advance at a pace comparable to genomics and transcriptomics. This breakthrough has had a profound impact on scientific research, driving exceptional scientific outcomes and expanding the possibilities for human health advancements.
